Role of Urokinase Plasminogen Activator Receptor in Gastric Cancer: A Potential Therapeutic Target

被引：11
作者：
Ma, Ying-Yu [1 ]
Tao, Hou-Quan [1 ]
机构：
[1] Key Lab Gastroenterol Zhejiang Prov, Hangzhou 310014, Zhejiang, Peoples R China
来源：
CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS | 2012年 / 27卷 / 05期
基金：
中国国家自然科学基金;
关键词：
gastric cancer; Helicobacter pylori; therapeutic target; uPAR; HELICOBACTER-PYLORI INFECTION; TGF-BETA SUPERFAMILY; UPAR MESSENGER-RNA; TYROSINE KINASE; CARCINOMA CELLS; LYSOPHOSPHATIDIC ACID; EPITHELIAL-CELLS; CLINICAL-SIGNIFICANCE; PROSTATE-CANCER; TUMOR INVASION;
D O I：
10.1089/cbr.2012.1232
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Recent advancements in cancer research have led to major breakthroughs; however, the impact on overall cancer-related death rate remains unacceptable. Thus, further insights into tumor markers and subsequent development of targeted therapies are urgently needed. For decades the urokinase plasminogen activator (uPA) system has been thought to drive tumor progression by mediating directed extracellular proteolysis on the surface of migrating or invading cells. Intervention with this proteolysis by targeting of uPA receptor (uPAR) has been proposed to represent a novel approach for inhibiting tumor progression. Recent data have provided new insights into the role of uPAR in gastric cancer progression. In addition to mediating proteolysis, this receptor also appears to mediate cell signaling, proliferation, and survival, and these observations have revealed novel ways to target uPAR. In this review, we discuss uPAR expression in gastric cancer, the relationship between uPAR and Helicobacter pylori, and recent insights into uPAR-signaling mechanisms. The role of uPAR as a cancer target in gastric cancer is also summarized.
引用
收藏
页码：285 / 290
页数：6
相关论文
共 68 条
[1]   Urokinase plasminogen activator receptor is expressed in invasive cells in gastric carcinomas from high- and low-risk countries [J].
Alpizar-Alpizar, Warner ;
Nielsen, Boye Schnack ;
Sierra, Rafaela ;
Illemann, Martin ;
Ramirez, Jose A. ;
Arias, Adriana ;
Duran, Sundry ;
Skarstein, Arne ;
Ovrebo, Kjell ;
Lund, Leif R. ;
Laerum, Ole D. .
INTERNATIONAL JOURNAL OF CANCER, 2010, 126 (02) :405-415
[2]   Serum lysophosphatidic acid is produced through diverse phospholipase pathways [J].
Aoki, J ;
Taira, A ;
Takanezawa, Y ;
Kishi, Y ;
Hama, K ;
Kishimoto, T ;
Mizuno, K ;
Saku, K ;
Taguchi, R ;
Arai, H .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (50) :48737-48744
[3]  
Asaka M, 2009, INT MED, V49, P633
[4]   Evolving role of uPA/uPAR system in human cancers [J].
Ass, Kathleen ;
Ahmad, Aamir ;
Azmi, Asfar S. ;
Sarkar, Sarah H. ;
Sarkar, Fazlul H. .
CANCER TREATMENT REVIEWS, 2008, 34 (02) :122-136
[5]   EGF stimulates uPAR expression and cell invasiveness through ERK, AP-1, and NF-κB signaling in human gastric carcinoma cells [J].
Baek, Min K. ;
Kim, Mi H. ;
Jang, Hee J. ;
Park, Jung S. ;
Chung, Ik J. ;
Shin, Boo A. ;
Ahn, Bong W. ;
Jung, Young D. .
ONCOLOGY REPORTS, 2008, 20 (06) :1569-1575
[6]   CD87 (urokinase-type plasminogen activator receptor), function and pathology in hematological disorders:: a review [J].
Béné, MC ;
Castoldi, G ;
Knapp, W ;
Rigolin, GM ;
Escribano, L ;
Lemez, P ;
Ludwig, WD ;
Matutes, E ;
Orfao, A ;
Lanza, F ;
van't Veer, M .
LEUKEMIA, 2004, 18 (03) :394-400
[7]   Urokinase system expression in gastric carcinoma - Prognostic impact in an independent patient series and first evidence of predictive value in preoperative biopsy and intestinal metaplasia specimens [J].
Beyer, BCM ;
Heiss, MM ;
Simon, EH ;
Gruetzner, KU ;
Babic, R ;
Jauch, KW ;
Schildberg, FW ;
Allgayer, H .
CANCER, 2006, 106 (05) :1026-1035
[8]   uPAR-uPA-PAI-l interactions and signaling: A vascular biologist's view [J].
Binder, Bernd R. ;
Mihaly, Judit ;
Prager, Gerald W. .
THROMBOSIS AND HAEMOSTASIS, 2007, 97 (03) :336-342
[9]   MIC-1, a novel macrophage inhibitory cytokine, is a divergent member of the TGF-beta superfamily [J].
Bootcov, MR ;
Bauskin, AR ;
Valenzuela, SM ;
Moore, AG ;
Bansal, M ;
He, XY ;
Zhang, HP ;
Donnellan, M ;
Mahler, S ;
Pryor, K ;
Walsh, BJ ;
Nicholson, RC ;
Fairlie, WD ;
Por, SB ;
Robbins, JM ;
Breit, SN .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (21) :11514-11519
[10]  
Buckhaults P, 2001, CANCER RES, V61, P6996
1234567